XORTX Therapeutics Inc. (NASDAQ:XRTX – Get Free Report) crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $2.56 and traded as high as $2.72. XORTX Therapeutics shares last traded at $2.37, with a volume of 33,670 shares.
Analyst Ratings Changes
Separately, Weiss Ratings restated a “sell (e+)” rating on shares of XORTX Therapeutics in a report on Friday, March 27th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company currently has an average rating of “Sell”.
View Our Latest Research Report on XRTX
XORTX Therapeutics Stock Performance
XORTX Therapeutics (NASDAQ:XRTX – Get Free Report) last issued its earnings results on Friday, May 15th. The technology company reported ($0.58) earnings per share for the quarter.
Institutional Investors Weigh In On XORTX Therapeutics
A hedge fund recently raised its stake in XORTX Therapeutics stock. Citadel Advisors LLC lifted its holdings in shares of XORTX Therapeutics Inc. (NASDAQ:XRTX – Free Report) by 124.4% during the 3rd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 86,326 shares of the technology company’s stock after acquiring an additional 47,858 shares during the period. Citadel Advisors LLC owned 1.24% of XORTX Therapeutics worth $70,000 at the end of the most recent reporting period. Hedge funds and other institutional investors own 0.23% of the company’s stock.
About XORTX Therapeutics
Xyratex Ltd (Xyratex) is a provider of data storage technology, including modular solutions for the enterprise data storage industry and hard disk drive (HDD) capital equipment for the HDD industry. Xyratex operates in two segments: Networked Storage Solutions (NSS) and Storage Infrastructure (SI). Its NSS products are primarily HDD based data storage subsystems and solutions, which it provides to original equipment manufacturers. Its SI products consist of HDD manufacturing process equipment, which it sells directly to manufacturers of HDDs and their component suppliers.
Featured Articles
- Five stocks we like better than XORTX Therapeutics
- Banks Are Buying Back Stock Hand Over Fist, Including These 3 Names
- 2 Aluminum Stocks Poised for Big Tariff-Related Gains
- AutoZone’s Pullback Sets Up a Long-Term Buying Opportunity
- AST SpaceMobile’s June Launch Plan Puts Its 2026 Satellite Goal Back in Focus
Receive News & Ratings for XORTX Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for XORTX Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
